Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Orthofix Medical Inc.

< Previous 1 2 3 Next >
Orthofix Medical to Present at Canaccord Genuity 2023 Musculoskeletal Conference
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Announces Full Commercial Launch and First Patient Cases of Mariner Deformity System
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Announces Publication of Data Demonstrating the Clinical Benefits of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX SPNE
Orthofix Medical Announces Participation in Upcoming Stifel Healthcare Conference
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Reports Third Quarter 2022 Results
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Announces First Patient Implants with Legacy Demineralized Bone Matrix for Spine, Pelvic and Extremities Procedures
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix and MTF Biologics Recognized with 2022 Spine Technology Award for Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX SPNE
Orthofix Announces Presentation of Long-Term Evidence Highlighting the Clinical Management of Cervical Disc Arthroplasty at North American Spine Society Annual Meeting
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Reports Second Quarter 2022 Results
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft Solutions
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Medical Schedules Second Quarter Earnings Release and Conference Call for August 5, 2022
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Medical and LimaCorporate Announce Partnership to Provide Solution for Patients with High Hip Dislocation for the US Market
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Reports First Quarter 2022 Results
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix and MTF Biologics Expand Partnership Agreement
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Announces New Business Unit President
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Announces FDA Clearance and First Patient Cases With the TrueLok EVO Ring Fixation System
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results
From Orthofix Medical Inc.
Via Business Wire
Tickers OFIX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.